{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:43:10Z","timestamp":1793090590038,"version":"4.5.0"},"reference-count":59,"publisher":"Cambridge University Press (CUP)","issue":"1","license":[{"start":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T00:00:00Z","timestamp":1733875200000},"content-version":"unspecified","delay-in-days":345,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ASHE"],"published-print":{"date-parts":[[2024]]},"abstract":"<jats:title>Abstract<\/jats:title>\n\t  <jats:p>A \u03b2\u2013lactam plus a macrolide or a respiratory fluoroquinolone alone is recommended as standard empiric antibacterial therapy for non-severe adults hospitalized with community-acquired pneumonia (CAP) per Infectious Diseases Society of America guidelines. However, the evidence in support of adding empiric atypical antibacterial therapy, and specifically the addition of a macrolide, is conflicting and should be balanced with additional factors: the necessity of covering atypical organisms, benefits of macrolide-associated immunomodulation, harms associated with antibiotic use, and selection for antibiotic-resistant organisms. In this review, we examine the role of atypical coverage in standard treatment regimens for patients admitted with non-severe CAP and specifically focus on the addition of macrolides to \u03b2\u2013lactams. We conclude that a subset of patients should not be given atypical coverage as part of their regimen.<\/jats:p>","DOI":"10.1017\/ash.2024.453","type":"journal-article","created":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T07:04:12Z","timestamp":1733900652000},"source":"Crossref","is-referenced-by-count":5,"title":["The role of empiric atypical antibiotic coverage in non-severe community-acquired pneumonia"],"prefix":"10.1017","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-0011-031X","authenticated-orcid":false,"given":"Whitney","family":"Hartlage","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3429-4655","authenticated-orcid":false,"given":"Hannah","family":"Imlay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4314-9644","authenticated-orcid":false,"given":"Emily S.","family":"Spivak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2024,12,11]]},"reference":[{"key":"S2732494X24004534_ref51","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy723"},{"key":"S2732494X24004534_ref15","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa508"},{"key":"S2732494X24004534_ref54","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0b013e3181779b53"},{"key":"S2732494X24004534_ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1500245"},{"key":"S2732494X24004534_ref59","doi-asserted-by":"publisher","DOI":"10.1378\/chest.123.5.1503"},{"key":"S2732494X24004534_ref16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1408544"},{"key":"S2732494X24004534_ref21","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.165.17.1992"},{"key":"S2732494X24004534_ref50","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2215145"},{"key":"S2732494X24004534_ref48","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ495"},{"key":"S2732494X24004534_ref31","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu873"},{"key":"S2732494X24004534_ref38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0138941"},{"key":"S2732494X24004534_ref42","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1300799"},{"key":"S2732494X24004534_ref55","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2020.05.598"},{"key":"S2732494X24004534_ref35","doi-asserted-by":"publisher","DOI":"10.1086\/593188"},{"key":"S2732494X24004534_ref2","first-page":"194","article-title":"Vital signs: improving antibiotic use among hospitalized patients","volume":"63","author":"Fridkin","year":"2014","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"S2732494X24004534_ref46","doi-asserted-by":"publisher","DOI":"10.1111\/resp.13233"},{"key":"S2732494X24004534_ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2017.10.006"},{"key":"S2732494X24004534_ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s11739-018-1840-z"},{"key":"S2732494X24004534_ref40","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a025395"},{"key":"S2732494X24004534_ref56","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.159.21.2562"},{"key":"S2732494X24004534_ref14","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2024.0077"},{"key":"S2732494X24004534_ref6","doi-asserted-by":"publisher","DOI":"10.1086\/513953"},{"key":"S2732494X24004534_ref25","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00058-15"},{"key":"S2732494X24004534_ref26","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac420"},{"key":"S2732494X24004534_ref52","doi-asserted-by":"publisher","DOI":"10.1111\/tid.12745"},{"key":"S2732494X24004534_ref13","doi-asserted-by":"publisher","DOI":"10.1136\/bmjqs-2021-013565"},{"key":"S2732494X24004534_ref20","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.38334.591586.82"},{"key":"S2732494X24004534_ref29","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.20949"},{"key":"S2732494X24004534_ref34","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2010.04506.x"},{"key":"S2732494X24004534_ref24","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1406330"},{"key":"S2732494X24004534_ref3","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201908-1581ST"},{"key":"S2732494X24004534_ref18","first-page":"294","article-title":"Clarithromycin for early anti-inflammatory responses in community-acquired pneumonia in Greece (ACCESS): a randomised, double-blind, placebo-controlled trial","volume":"12","author":"Giamarellos-Bourboulis","year":"2024","journal-title":"Lancet"},{"key":"S2732494X24004534_ref33","doi-asserted-by":"publisher","DOI":"10.3201\/eid2005.130966"},{"key":"S2732494X24004534_ref45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001048"},{"key":"S2732494X24004534_ref41","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1003833"},{"key":"S2732494X24004534_ref10","doi-asserted-by":"publisher","DOI":"10.1086\/511159"},{"key":"S2732494X24004534_ref36","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa040216"},{"key":"S2732494X24004534_ref57","doi-asserted-by":"publisher","DOI":"10.1378\/chest.119.5.1420"},{"key":"S2732494X24004534_ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2021.10.022"},{"key":"S2732494X24004534_ref39","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.35.7.1267"},{"key":"S2732494X24004534_ref53","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2015.10.006"},{"key":"S2732494X24004534_ref9","doi-asserted-by":"publisher","DOI":"10.1086\/380488"},{"key":"S2732494X24004534_ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2013.03.003"},{"key":"S2732494X24004534_ref43","unstructured":"43 U.S. Food and Drug Administration. Drug Safety Communication: Azithromycin (Zithromax or Zmax) and the Risk of Potentially Fatal Heart Rhythms. 2013. https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-safety-communication-azithromycin-zithromax-or-zmax-and-risk-potentially-fatal-heart"},{"key":"S2732494X24004534_ref27","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofab063"},{"key":"S2732494X24004534_ref8","doi-asserted-by":"publisher","DOI":"10.1086\/313954"},{"key":"S2732494X24004534_ref1","volume-title":"Most Frequent Principal Diagnoses for Inpatient Stays in U.S. Hospitals, 2018","author":"McDermott","year":"2021"},{"key":"S2732494X24004534_ref58","doi-asserted-by":"publisher","DOI":"10.1345\/aph.19174"},{"key":"S2732494X24004534_ref23","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2014.4887"},{"key":"S2732494X24004534_ref37","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02931-14"},{"key":"S2732494X24004534_ref49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiac.2017.09.001"},{"key":"S2732494X24004534_ref28","volume-title":"Kucers\u2019 the Use of Antibiotics: A Clinical Review of Antibacterial, Antifungal, Antiparasitic and Antiviral Drugs","author":"Grayson","year":"2018"},{"key":"S2732494X24004534_ref22","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-017-2495-5"},{"key":"S2732494X24004534_ref30","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu1162"},{"key":"S2732494X24004534_ref32","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(13)70036-7"},{"key":"S2732494X24004534_ref4","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2009.121434"},{"key":"S2732494X24004534_ref7","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1997.00440360129015"},{"key":"S2732494X24004534_ref44","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cix647"},{"key":"S2732494X24004534_ref19","first-page":"CD004418","article-title":"Empiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized adults","volume":"2012","author":"Eliakim-Raz","year":"2012","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Antimicrobial Stewardship &amp; Healthcare Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S2732494X24004534","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T07:04:18Z","timestamp":1733900658000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S2732494X24004534\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024]]}},"alternative-id":["S2732494X24004534"],"URL":"https:\/\/doi.org\/10.1017\/ash.2024.453","relation":{},"ISSN":["2732-494X"],"issn-type":[{"value":"2732-494X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]},"article-number":"e214"}}